Hongli Lin

991 total citations
28 papers, 396 citations indexed

About

Hongli Lin is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Hongli Lin has authored 28 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Hongli Lin's work include Renal Diseases and Glomerulopathies (9 papers), Dialysis and Renal Disease Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Hongli Lin is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Dialysis and Renal Disease Management (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Hongli Lin collaborates with scholars based in China, Netherlands and Sweden. Hongli Lin's co-authors include Xiangmei Chen, Xuefeng Sun, Zhaohui Ni, Nan Shen, Yiyao Deng, Taihua Wu, Nan Wang, Xiaojuan Bai, Lulu Han and Zhihong Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Hongli Lin

26 papers receiving 392 citations

Peers

Countries citing papers authored by Hongli Lin

Since Specialization

Citations

This map shows the geographic impact of Hongli Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Lin more than expected).

Fields of papers citing papers by Hongli Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongli Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Lin. The network helps show where Hongli Lin may publish in the future.

Co-authorship network of co-authors of Hongli Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hongli Lin. A scholar is included among the top collaborators of Hongli Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongli Lin. Hongli Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia 2025 ·Kidney International Reports ·(unknown), Xuefeng Sun, Li Zhang, Hongli Lin, Niansong Wang, Yuehong Li, (unknown), Ping Fu, Hong Cheng, Zhiyong Guo, Wanhong Lu, Yani He, Fengmin Shao, Qiang He, Yiqing Wu, Cuihua Huang, Shuting Pan, Guangyan Cai, Xiangmei Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Exosomal miR-27a-5p inhibits indoxyl sulfate-induced cardiac dysfunction by targeting the USF2/FUT8 axis 2025 ·Free Radical Biology and Medicine ·(unknown), (unknown), Nan Wang, (unknown), (unknown), (unknown), Xu Zhang, Weidong Wang, Hui He, Ziran Wang, Huiyi Song, (unknown), (unknown), (unknown), Fan Yang, (unknown), (unknown), (unknown), Hongli Lin	1
3	Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report 2023 ·World Journal of Clinical Cases ·Jinling Wang, Yanling Sun, Zhe Kang, Shengkun Zhang, Chunxin Yu, Wan Zhang, (unknown), Hongli Lin	5
4	Recent advances in the involvement of epigenetics in the pathogenesis of systemic lupus erythematosus 2023 ·Clinical Immunology ·Hongyan Zhou, Q. Luo, Hua Sui, (unknown), (unknown), (unknown), Qing Guan, Yue Zhou, (unknown), Yan Shi, Yu Sun, Hongli Lin, Dapeng Wang	9
5	Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial 2022 ·Phytomedicine ·Xuefeng Sun, Ping Li, Hongli Lin, Zhaohui Ni, Yongli Zhan, Guangyan Cai, Chao Liu, Qinkai Chen, Wenge Wang, Xiaoqin Wang, (unknown), Peng Li, (unknown), Hongguang Zheng, Niansong Wang, Lining Miao, (unknown), Zhiyong Guo, Yong Wang, Xiangmei Chen	9
6	Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression 2021 ·Renal Failure ·Changqing Yu, Ning Yang, Weidong Wang, (unknown), (unknown), Hongli Lin, (unknown)	6
7	Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial 2020 ·Phytomedicine ·Ping Li, Hongli Lin, Zhaohui Ni, Yongli Zhan, Yani He, (unknown), Jingai Fang, Niansong Wang, Wenge Li, Guangyan Cai, Yizhi Chen, Peiqing Zhang, Xiaoqin Wang, Qinkai Chen, Zhenjiang Li, Xuefeng Sun, Xiangmei Chen	28
8	Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats 2018 ·Kidney International ·(unknown), Nan Shen, Nan Wang, Weidong Wang, (unknown), (unknown), Juan Jesús Carrero, (unknown), Yiyao Deng, Zhitong Li, Hongli Lin, Taihua Wu	30
9	Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey 2018 ·Clinical and Experimental Hypertension ·Ying Zheng, Li Yoong Tang, Xiangmei Chen, Guangyan Cai, Wenge Li, Zhaohui Ni, Wei Shi, Xiaoqiang Ding, Hongli Lin	4
10	Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial 2017 ·Trials ·Ping Li, Yizhi Chen, Hongli Lin, Zhaohui Ni, Yongli Zhan, Rong Wang, Hongtao Yang, Jingai Fang, Niansong Wang, Wenge Li, Xuefeng Sun, Xiangmei Chen	27
11	Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation 2017 ·Scientific Reports ·Nan Wang, Yiyao Deng, Anqi Liu, Nan Shen, Weidong Wang, (unknown), (unknown), Shuangxin Li, (unknown), Taihua Wu, Hongli Lin	51
12	Blocking Posttranslational Core Fucosylation Ameliorates Rat Peritoneal Mesothelial Cell Epithelial-Mesenchymal Transition 2017 ·Chinese Medical Journal ·(unknown), Nan Wang, Weidong Wang, (unknown), (unknown), Ling‐Yu Wang, Yiyao Deng, Dapeng Wang, Hongli Lin	10
13	Keto-supplemented low protein diet: A valid therapeutic approach for patients with steroid-resistant proteinuria during early-stage chronic kidney disease 2015 ·The journal of nutrition health & aging ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lin Yang, Hongli Lin	17
14	Intermittent high-volume hemofiltration promotes remission in steroid-resistant idiopathic nephrotic syndrome 2015 ·Renal Failure ·Hua Xie, (unknown), Hongli Lin, Ping Li, Ji‐Lin Chen, (unknown), (unknown)	3
15	Current status of anticoagulant treatments and improvements for hemodialysis patients in northern Chinese cities: a five-year comparative study 2014 ·Chinese Medical Journal ·(unknown), Xuefeng Sun, Hongli Lin, (unknown), (unknown), (unknown), Jijun Li, (unknown), Yong Wang, Hanyu Zhu, Xiangmei Chen	4
16	Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial 2014 ·Trials ·Jia Kou, Jie Wu, (unknown), Yani He, Jingai Fang, Yueyi Deng, Yuansheng Xie, (unknown), Hongli Lin, Guangyan Cai, Xiangmei Chen	7
17	The Clinical Significance and Risk Factors of Anti-Platelet Factor 4/heparin Antibody on Maintenance Hemodialysis Patients: A Two-Year Prospective Follow-up 2013 ·PLoS ONE ·Delong Zhao, Xuefeng Sun, Li Yao, Hongli Lin, Jijun Li, (unknown), (unknown), (unknown), Jianrong Zhang, Mingxu Li, (unknown), Yang Yang, Shimin Jiang, (unknown), Hanyu Zhu, Xiangmei Chen	18
18	Association between kidney and cardiac diastolic function in Chinese subjects without overt disease: correlation with ageing and inflammatory markers 2011 ·European Journal of Clinical Investigation ·Lulu Han, Xiaojuan Bai, Hongli Lin, Xuefeng Sun, Xiangmei Chen	5
19	Evaluation of Biological Aging Process – A Population-Based Study of Healthy People in China 2009 ·Gerontology ·Xiaojuan Bai, Lulu Han, Qiang Liu, Haiyan Shan, Hongli Lin, Xuefeng Sun, Xiangmei Chen	41
20	[Epidemiology of anticoagulation for hemodialysis patients: survey of 842 cases in seven hemodialysis centers]. 2009 ·PubMed ·Xuefeng Sun, (unknown), Yu Wang, Lirong Hao, Hongli Lin, (unknown), Jijun Li, Xiangmei Chen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact